Humoral response to coronavirus disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritis

OBJECTIVES: Humoral response to vaccines in RA patients treated with rituximab (RTX) in standard dosages (≥1000 mg) is decreased. Ultra-low dosages (500 or 200 mg) may have better response. Also, timing after latest RTX infusion may be an important variable. We aimed to investigate the influence of...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Togt, Céleste J T, Ten Cate, David F, den Broeder, Nathan, Rahamat-Langendoen, Janette, van den Bemt, Bart J F, den Broeder, Alfons A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992349/
https://www.ncbi.nlm.nih.gov/pubmed/35377422
http://dx.doi.org/10.1093/rheumatology/keac206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992349/
https://www.ncbi.nlm.nih.gov/pubmed/35377422
http://dx.doi.org/10.1093/rheumatology/keac206

Ejemplares similares